1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Nuclear Medicine Outlook 2020

Global Nuclear Medicine Outlook 2020

  • December 2015
  • -
  • RNCOS
  • -
  • 75 pages

Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.

According to our research report, "Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.

Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.

Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.

The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.

Table Of Contents

Global Nuclear Medicine Outlook 2020
1. Analyst View
2. Research Methodology
3. Drivers and Challenges
3.1 Drivers
3.1.1 Rising Incidences of Cancer and Cardiovascular Diseases
3.1.2 Increasing Use of SPECT and PET Scans
3.1.3 Rising Ageing Population
3.1.4 Advances in Radiotracers
3.2 Challenges
3.2.1 Shut Down of Nuclear Reactors
3.2.2 Short Half-life of Radiopharmaceuticals
3.2.3 Production and Quality Control Challenges
3.2.4 Reimbursement Issues
4. Industry Overview
4.1 Nuclear Medicine Diagnostics Market
4.1.1 Diagnostic Radiopharmaceuticals Market
4.1.2 Nuclear Medicine Equipments Market
4.2 Nuclear Medicine Therapeutics Market
4.3 Nuclear Medicine Market by Geography
5. Recent Trends and Developments
5.1 Nuclear Medicine: Aiding the Growth of Personalized Medicine
5.2 Shift from SPECT to PET Systems
5.3 Hybrid Imaging Propelling Market Growth
5.4 Efforts Underway to Overcome Molybdenum-99 Shortage
5.5 Consolidation in the Market
5.6 Increasing Number of Clinical Trials
6. Competitive Landscape
6.1 Advanced Accelerator Applications
6.2 Mallinckrodt
6.3 Lantheus Medical Imaging
6.4 IBA
6.5 Cardinal Health Inc.
6.6 Nordion Inc.
6.7 Siemens Healthcare
6.8 GE Healthcare

List of Figures:

Figure 3-1: World - Number of Cancer Cases (Million), 2015 and 2035
Figure 3-2: World - Population Aged 60 and Above (Billion), 2014 and 2050
Figure 4-1: Global - Nuclear Medicine Market (Billion US$), 2014-2020
Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
Figure 4-6: Global - Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
Figure 4-7: Medical Procedures Using Technetium - 99m (%), 2014
Figure 4-8: Global - Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
Figure 4-9: Global - Nuclear Medicine Equipments Market (Billion US$), 2014-2020
Figure 4-10: Global - Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
Figure 4-11: Global - Nuclear Medicine Market by Geographies (%), 2014

List of Tables:

Table 5-1: Recent MandA in the Global Nuclear Medicine Market (2014 - 2015)
Table 5-2: Major Products in the Pipeline
Table 6-1: Advanced Accelerator Applications - Revenue by Product Category (Million Euro), 2013 and 2014
Table 6-2: Advanced Accelerator Applications - Revenue by Countries (Million Euro), 2013 and 2014
Table 6-3: Advanced Accelerator Applications - Strengths and Weaknesses
Table 6-4: Mallinckrodt - Revenue by Business Segments (Million US$), 2013 and 2014
Table 6-5: Mallinckrodt - Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 and 2014
Table 6-6: Mallinckrodt - Strengths and Weaknesses
Table 6-7: Lantheus Medical Imaging - Revenue by Products (Million US$), 2013 and 2014
Table 6-8: Lantheus Medical Imaging - Strengths and Weaknesses
Table 6-9: IBA - Revenue by Business Segments (Million Euro), 2013 and 2014
Table 6-10: IBA - Strengths and Weaknesses
Table 6-11: Cardinal Health Inc. - Revenue by Business Segments (Billion US$), 2013 and 2014
Table 6-12: Cardinal Health Inc. - Strengths and Weaknesses
Table 6-13: Nordion Inc. - Strengths and Weaknesses
Table 6-14: Siemens Healthcare - Strengths and Weaknesses
Table 6-15: GE Healthcare - Strengths and Weaknesses

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.